nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A4—type 2 diabetes mellitus	0.216	1	CbGaD
Oxycodone—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0494	0.109	CbGbCtD
Oxycodone—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0494	0.109	CbGbCtD
Oxycodone—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0371	0.0814	CbGbCtD
Oxycodone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.03	0.0659	CbGbCtD
Oxycodone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0296	0.065	CbGbCtD
Oxycodone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0277	0.0608	CbGbCtD
Oxycodone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0264	0.058	CbGbCtD
Oxycodone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0241	0.053	CbGbCtD
Oxycodone—CYP3A5—Losartan—type 2 diabetes mellitus	0.0229	0.0503	CbGbCtD
Oxycodone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0227	0.0499	CbGbCtD
Oxycodone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0218	0.0479	CbGbCtD
Oxycodone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0211	0.0463	CbGbCtD
Oxycodone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0191	0.0419	CbGbCtD
Oxycodone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0145	0.0318	CbGbCtD
Oxycodone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0139	0.0304	CbGbCtD
Oxycodone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0139	0.0304	CbGbCtD
Oxycodone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0131	0.0288	CbGbCtD
Oxycodone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00976	0.0214	CbGbCtD
Oxycodone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00893	0.0196	CbGbCtD
Oxycodone—Dihydrocodeine—CYP3A4—type 2 diabetes mellitus	0.000337	0.152	CrCbGaD
Oxycodone—Oxymorphone—CYP3A4—type 2 diabetes mellitus	0.000295	0.133	CrCbGaD
Oxycodone—Ethylmorphine—CYP3A4—type 2 diabetes mellitus	0.000282	0.127	CrCbGaD
Oxycodone—Hydrocodone—CYP3A4—type 2 diabetes mellitus	0.000258	0.116	CrCbGaD
Oxycodone—Codeine—CYP3A4—type 2 diabetes mellitus	0.000225	0.101	CrCbGaD
Oxycodone—Naloxone—CYP3A4—type 2 diabetes mellitus	0.000215	0.0971	CrCbGaD
Oxycodone—Hydromorphone—CYP3A4—type 2 diabetes mellitus	0.000214	0.0964	CrCbGaD
Oxycodone—Galantamine—CYP3A4—type 2 diabetes mellitus	0.000204	0.092	CrCbGaD
Oxycodone—Naloxone—ALB—type 2 diabetes mellitus	0.000188	0.0847	CrCbGaD
Oxycodone—Shock—Metformin—type 2 diabetes mellitus	9.52e-05	0.000373	CcSEcCtD
Oxycodone—Insomnia—Orlistat—type 2 diabetes mellitus	9.49e-05	0.000372	CcSEcCtD
Oxycodone—Malaise—Losartan—type 2 diabetes mellitus	9.49e-05	0.000372	CcSEcCtD
Oxycodone—Anxiety—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000372	CcSEcCtD
Oxycodone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.49e-05	0.000371	CcSEcCtD
Oxycodone—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.49e-05	0.000371	CcSEcCtD
Oxycodone—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.47e-05	0.000371	CcSEcCtD
Oxycodone—Vertigo—Losartan—type 2 diabetes mellitus	9.46e-05	0.00037	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.46e-05	0.00037	CcSEcCtD
Oxycodone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.46e-05	0.00037	CcSEcCtD
Oxycodone—Somnolence—Valsartan—type 2 diabetes mellitus	9.44e-05	0.00037	CcSEcCtD
Oxycodone—Syncope—Losartan—type 2 diabetes mellitus	9.44e-05	0.00037	CcSEcCtD
Oxycodone—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.43e-05	0.000369	CcSEcCtD
Oxycodone—Leukopenia—Losartan—type 2 diabetes mellitus	9.42e-05	0.000369	CcSEcCtD
Oxycodone—Discomfort—Irbesartan—type 2 diabetes mellitus	9.41e-05	0.000368	CcSEcCtD
Oxycodone—Skin disorder—Metformin—type 2 diabetes mellitus	9.4e-05	0.000368	CcSEcCtD
Oxycodone—Immune system disorder—Ramipril—type 2 diabetes mellitus	9.37e-05	0.000367	CcSEcCtD
Oxycodone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.35e-05	0.000366	CcSEcCtD
Oxycodone—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.35e-05	0.000366	CcSEcCtD
Oxycodone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000366	CcSEcCtD
Oxycodone—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.32e-05	0.000365	CcSEcCtD
Oxycodone—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.31e-05	0.000365	CcSEcCtD
Oxycodone—Palpitations—Losartan—type 2 diabetes mellitus	9.3e-05	0.000364	CcSEcCtD
Oxycodone—Nausea—Glimepiride—type 2 diabetes mellitus	9.27e-05	0.000363	CcSEcCtD
Oxycodone—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.25e-05	0.000362	CcSEcCtD
Oxycodone—Nausea—Sitagliptin—type 2 diabetes mellitus	9.25e-05	0.000362	CcSEcCtD
Oxycodone—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.24e-05	0.000362	CcSEcCtD
Oxycodone—Asthenia—Glyburide—type 2 diabetes mellitus	9.24e-05	0.000362	CcSEcCtD
Oxycodone—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.23e-05	0.000362	CcSEcCtD
Oxycodone—Anorexia—Metformin—type 2 diabetes mellitus	9.22e-05	0.000361	CcSEcCtD
Oxycodone—Cough—Losartan—type 2 diabetes mellitus	9.19e-05	0.00036	CcSEcCtD
Oxycodone—Urticaria—Gliclazide—type 2 diabetes mellitus	9.19e-05	0.00036	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.17e-05	0.000359	CcSEcCtD
Oxycodone—Fatigue—Valsartan—type 2 diabetes mellitus	9.16e-05	0.000359	CcSEcCtD
Oxycodone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.14e-05	0.000358	CcSEcCtD
Oxycodone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.14e-05	0.000358	CcSEcCtD
Oxycodone—Oedema—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.000357	CcSEcCtD
Oxycodone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.000357	CcSEcCtD
Oxycodone—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.13e-05	0.000357	CcSEcCtD
Oxycodone—Pruritus—Glyburide—type 2 diabetes mellitus	9.11e-05	0.000357	CcSEcCtD
Oxycodone—Mental disorder—Ramipril—type 2 diabetes mellitus	9.08e-05	0.000356	CcSEcCtD
Oxycodone—Constipation—Valsartan—type 2 diabetes mellitus	9.08e-05	0.000356	CcSEcCtD
Oxycodone—Infection—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000355	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.06e-05	0.000355	CcSEcCtD
Oxycodone—Fatigue—Orlistat—type 2 diabetes mellitus	9.05e-05	0.000354	CcSEcCtD
Oxycodone—Hypotension—Metformin—type 2 diabetes mellitus	9.04e-05	0.000354	CcSEcCtD
Oxycodone—Malnutrition—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000353	CcSEcCtD
Oxycodone—Shock—Irbesartan—type 2 diabetes mellitus	8.98e-05	0.000352	CcSEcCtD
Oxycodone—Pain—Orlistat—type 2 diabetes mellitus	8.98e-05	0.000351	CcSEcCtD
Oxycodone—Chest pain—Losartan—type 2 diabetes mellitus	8.96e-05	0.000351	CcSEcCtD
Oxycodone—Arthralgia—Losartan—type 2 diabetes mellitus	8.96e-05	0.000351	CcSEcCtD
Oxycodone—Myalgia—Losartan—type 2 diabetes mellitus	8.96e-05	0.000351	CcSEcCtD
Oxycodone—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.96e-05	0.000351	CcSEcCtD
Oxycodone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.95e-05	0.000351	CcSEcCtD
Oxycodone—Anxiety—Losartan—type 2 diabetes mellitus	8.93e-05	0.00035	CcSEcCtD
Oxycodone—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.91e-05	0.000349	CcSEcCtD
Oxycodone—Rash—Bromocriptine—type 2 diabetes mellitus	8.88e-05	0.000348	CcSEcCtD
Oxycodone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.87e-05	0.000347	CcSEcCtD
Oxycodone—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.87e-05	0.000347	CcSEcCtD
Oxycodone—Tension—Ramipril—type 2 diabetes mellitus	8.86e-05	0.000347	CcSEcCtD
Oxycodone—Discomfort—Losartan—type 2 diabetes mellitus	8.86e-05	0.000347	CcSEcCtD
Oxycodone—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.84e-05	0.000346	CcSEcCtD
Oxycodone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.83e-05	0.000346	CcSEcCtD
Oxycodone—Headache—Bromocriptine—type 2 diabetes mellitus	8.82e-05	0.000346	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.81e-05	0.000345	CcSEcCtD
Oxycodone—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.81e-05	0.000345	CcSEcCtD
Oxycodone—Nervousness—Ramipril—type 2 diabetes mellitus	8.77e-05	0.000343	CcSEcCtD
Oxycodone—Dry mouth—Losartan—type 2 diabetes mellitus	8.77e-05	0.000343	CcSEcCtD
Oxycodone—Anorexia—Irbesartan—type 2 diabetes mellitus	8.7e-05	0.000341	CcSEcCtD
Oxycodone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.69e-05	0.00034	CcSEcCtD
Oxycodone—Paraesthesia—Metformin—type 2 diabetes mellitus	8.69e-05	0.00034	CcSEcCtD
Oxycodone—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.68e-05	0.00034	CcSEcCtD
Oxycodone—Confusional state—Losartan—type 2 diabetes mellitus	8.66e-05	0.000339	CcSEcCtD
Oxycodone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.65e-05	0.000339	CcSEcCtD
Oxycodone—Dyspnoea—Metformin—type 2 diabetes mellitus	8.63e-05	0.000338	CcSEcCtD
Oxycodone—Somnolence—Metformin—type 2 diabetes mellitus	8.6e-05	0.000337	CcSEcCtD
Oxycodone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.59e-05	0.000336	CcSEcCtD
Oxycodone—Oedema—Losartan—type 2 diabetes mellitus	8.59e-05	0.000336	CcSEcCtD
Oxycodone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.58e-05	0.000336	CcSEcCtD
Oxycodone—Infection—Losartan—type 2 diabetes mellitus	8.54e-05	0.000334	CcSEcCtD
Oxycodone—Hypotension—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.000334	CcSEcCtD
Oxycodone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.52e-05	0.000334	CcSEcCtD
Oxycodone—Dyspepsia—Metformin—type 2 diabetes mellitus	8.52e-05	0.000333	CcSEcCtD
Oxycodone—Tremor—Ramipril—type 2 diabetes mellitus	8.46e-05	0.000331	CcSEcCtD
Oxycodone—Shock—Losartan—type 2 diabetes mellitus	8.45e-05	0.000331	CcSEcCtD
Oxycodone—Urticaria—Valsartan—type 2 diabetes mellitus	8.44e-05	0.00033	CcSEcCtD
Oxycodone—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.43e-05	0.00033	CcSEcCtD
Oxycodone—Decreased appetite—Metformin—type 2 diabetes mellitus	8.41e-05	0.000329	CcSEcCtD
Oxycodone—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.4e-05	0.000329	CcSEcCtD
Oxycodone—Tachycardia—Losartan—type 2 diabetes mellitus	8.39e-05	0.000328	CcSEcCtD
Oxycodone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.38e-05	0.000328	CcSEcCtD
Oxycodone—Nausea—Bromocriptine—type 2 diabetes mellitus	8.37e-05	0.000328	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.35e-05	0.000327	CcSEcCtD
Oxycodone—Fatigue—Metformin—type 2 diabetes mellitus	8.34e-05	0.000327	CcSEcCtD
Oxycodone—Urticaria—Orlistat—type 2 diabetes mellitus	8.34e-05	0.000327	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.32e-05	0.000326	CcSEcCtD
Oxycodone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.31e-05	0.000325	CcSEcCtD
Oxycodone—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.3e-05	0.000325	CcSEcCtD
Oxycodone—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.3e-05	0.000325	CcSEcCtD
Oxycodone—Asthenia—Gliclazide—type 2 diabetes mellitus	8.3e-05	0.000325	CcSEcCtD
Oxycodone—Agitation—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000325	CcSEcCtD
Oxycodone—Constipation—Metformin—type 2 diabetes mellitus	8.27e-05	0.000324	CcSEcCtD
Oxycodone—Angioedema—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000323	CcSEcCtD
Oxycodone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.000321	CcSEcCtD
Oxycodone—Anorexia—Losartan—type 2 diabetes mellitus	8.19e-05	0.000321	CcSEcCtD
Oxycodone—Vomiting—Glyburide—type 2 diabetes mellitus	8.19e-05	0.000321	CcSEcCtD
Oxycodone—Pruritus—Gliclazide—type 2 diabetes mellitus	8.18e-05	0.00032	CcSEcCtD
Oxycodone—Malaise—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000319	CcSEcCtD
Oxycodone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000319	CcSEcCtD
Oxycodone—Rash—Glyburide—type 2 diabetes mellitus	8.12e-05	0.000318	CcSEcCtD
Oxycodone—Somnolence—Irbesartan—type 2 diabetes mellitus	8.12e-05	0.000318	CcSEcCtD
Oxycodone—Dermatitis—Glyburide—type 2 diabetes mellitus	8.11e-05	0.000318	CcSEcCtD
Oxycodone—Vertigo—Ramipril—type 2 diabetes mellitus	8.11e-05	0.000318	CcSEcCtD
Oxycodone—Syncope—Ramipril—type 2 diabetes mellitus	8.1e-05	0.000317	CcSEcCtD
Oxycodone—Leukopenia—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000316	CcSEcCtD
Oxycodone—Headache—Glyburide—type 2 diabetes mellitus	8.07e-05	0.000316	CcSEcCtD
Oxycodone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000315	CcSEcCtD
Oxycodone—Hypotension—Losartan—type 2 diabetes mellitus	8.03e-05	0.000314	CcSEcCtD
Oxycodone—Palpitations—Ramipril—type 2 diabetes mellitus	7.98e-05	0.000312	CcSEcCtD
Oxycodone—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.97e-05	0.000312	CcSEcCtD
Oxycodone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.94e-05	0.000311	CcSEcCtD
Oxycodone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000311	CcSEcCtD
Oxycodone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.91e-05	0.00031	CcSEcCtD
Oxycodone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.91e-05	0.00031	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.88e-05	0.000309	CcSEcCtD
Oxycodone—Cough—Ramipril—type 2 diabetes mellitus	7.88e-05	0.000308	CcSEcCtD
Oxycodone—Fatigue—Irbesartan—type 2 diabetes mellitus	7.87e-05	0.000308	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.83e-05	0.000306	CcSEcCtD
Oxycodone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.83e-05	0.000306	CcSEcCtD
Oxycodone—Convulsion—Ramipril—type 2 diabetes mellitus	7.82e-05	0.000306	CcSEcCtD
Oxycodone—Pain—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000306	CcSEcCtD
Oxycodone—Constipation—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000306	CcSEcCtD
Oxycodone—Insomnia—Losartan—type 2 diabetes mellitus	7.77e-05	0.000304	CcSEcCtD
Oxycodone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.73e-05	0.000303	CcSEcCtD
Oxycodone—Paraesthesia—Losartan—type 2 diabetes mellitus	7.72e-05	0.000302	CcSEcCtD
Oxycodone—Urticaria—Metformin—type 2 diabetes mellitus	7.69e-05	0.000301	CcSEcCtD
Oxycodone—Arthralgia—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000301	CcSEcCtD
Oxycodone—Chest pain—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000301	CcSEcCtD
Oxycodone—Myalgia—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000301	CcSEcCtD
Oxycodone—Dyspnoea—Losartan—type 2 diabetes mellitus	7.66e-05	0.0003	CcSEcCtD
Oxycodone—Anxiety—Ramipril—type 2 diabetes mellitus	7.66e-05	0.0003	CcSEcCtD
Oxycodone—Nausea—Glyburide—type 2 diabetes mellitus	7.65e-05	0.000299	CcSEcCtD
Oxycodone—Abdominal pain—Metformin—type 2 diabetes mellitus	7.65e-05	0.000299	CcSEcCtD
Oxycodone—Dizziness—Gliclazide—type 2 diabetes mellitus	7.65e-05	0.000299	CcSEcCtD
Oxycodone—Somnolence—Losartan—type 2 diabetes mellitus	7.64e-05	0.000299	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.63e-05	0.000299	CcSEcCtD
Oxycodone—Asthenia—Valsartan—type 2 diabetes mellitus	7.62e-05	0.000298	CcSEcCtD
Oxycodone—Discomfort—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000297	CcSEcCtD
Oxycodone—Dyspepsia—Losartan—type 2 diabetes mellitus	7.56e-05	0.000296	CcSEcCtD
Oxycodone—Asthenia—Orlistat—type 2 diabetes mellitus	7.53e-05	0.000295	CcSEcCtD
Oxycodone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000295	CcSEcCtD
Oxycodone—Pruritus—Valsartan—type 2 diabetes mellitus	7.52e-05	0.000294	CcSEcCtD
Oxycodone—Dry mouth—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000294	CcSEcCtD
Oxycodone—Decreased appetite—Losartan—type 2 diabetes mellitus	7.47e-05	0.000292	CcSEcCtD
Oxycodone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.47e-05	0.000292	CcSEcCtD
Oxycodone—Confusional state—Ramipril—type 2 diabetes mellitus	7.43e-05	0.000291	CcSEcCtD
Oxycodone—Pruritus—Orlistat—type 2 diabetes mellitus	7.43e-05	0.000291	CcSEcCtD
Oxycodone—Fatigue—Losartan—type 2 diabetes mellitus	7.41e-05	0.00029	CcSEcCtD
Oxycodone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000288	CcSEcCtD
Oxycodone—Oedema—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000288	CcSEcCtD
Oxycodone—Vomiting—Gliclazide—type 2 diabetes mellitus	7.35e-05	0.000288	CcSEcCtD
Oxycodone—Pain—Losartan—type 2 diabetes mellitus	7.35e-05	0.000288	CcSEcCtD
Oxycodone—Constipation—Losartan—type 2 diabetes mellitus	7.35e-05	0.000288	CcSEcCtD
Oxycodone—Rash—Gliclazide—type 2 diabetes mellitus	7.29e-05	0.000285	CcSEcCtD
Oxycodone—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.28e-05	0.000285	CcSEcCtD
Oxycodone—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.27e-05	0.000285	CcSEcCtD
Oxycodone—Urticaria—Irbesartan—type 2 diabetes mellitus	7.25e-05	0.000284	CcSEcCtD
Oxycodone—Shock—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000284	CcSEcCtD
Oxycodone—Headache—Gliclazide—type 2 diabetes mellitus	7.24e-05	0.000284	CcSEcCtD
Oxycodone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000283	CcSEcCtD
Oxycodone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000283	CcSEcCtD
Oxycodone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000283	CcSEcCtD
Oxycodone—Tachycardia—Ramipril—type 2 diabetes mellitus	7.19e-05	0.000282	CcSEcCtD
Oxycodone—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.18e-05	0.000281	CcSEcCtD
Oxycodone—Skin disorder—Ramipril—type 2 diabetes mellitus	7.16e-05	0.00028	CcSEcCtD
Oxycodone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000279	CcSEcCtD
Oxycodone—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.08e-05	0.000277	CcSEcCtD
Oxycodone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.03e-05	0.000275	CcSEcCtD
Oxycodone—Dizziness—Valsartan—type 2 diabetes mellitus	7.03e-05	0.000275	CcSEcCtD
Oxycodone—Anorexia—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000275	CcSEcCtD
Oxycodone—Dizziness—Orlistat—type 2 diabetes mellitus	6.94e-05	0.000272	CcSEcCtD
Oxycodone—Asthenia—Metformin—type 2 diabetes mellitus	6.94e-05	0.000272	CcSEcCtD
Oxycodone—Hypotension—Ramipril—type 2 diabetes mellitus	6.88e-05	0.00027	CcSEcCtD
Oxycodone—Nausea—Gliclazide—type 2 diabetes mellitus	6.87e-05	0.000269	CcSEcCtD
Oxycodone—Pruritus—Metformin—type 2 diabetes mellitus	6.84e-05	0.000268	CcSEcCtD
Oxycodone—Urticaria—Losartan—type 2 diabetes mellitus	6.83e-05	0.000267	CcSEcCtD
Oxycodone—Abdominal pain—Losartan—type 2 diabetes mellitus	6.79e-05	0.000266	CcSEcCtD
Oxycodone—Body temperature increased—Losartan—type 2 diabetes mellitus	6.79e-05	0.000266	CcSEcCtD
Oxycodone—Vomiting—Valsartan—type 2 diabetes mellitus	6.75e-05	0.000264	CcSEcCtD
Oxycodone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.000263	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000263	CcSEcCtD
Oxycodone—Rash—Valsartan—type 2 diabetes mellitus	6.7e-05	0.000262	CcSEcCtD
Oxycodone—Dermatitis—Valsartan—type 2 diabetes mellitus	6.69e-05	0.000262	CcSEcCtD
Oxycodone—Vomiting—Orlistat—type 2 diabetes mellitus	6.67e-05	0.000261	CcSEcCtD
Oxycodone—Insomnia—Ramipril—type 2 diabetes mellitus	6.66e-05	0.000261	CcSEcCtD
Oxycodone—Headache—Valsartan—type 2 diabetes mellitus	6.66e-05	0.000261	CcSEcCtD
Oxycodone—Diarrhoea—Metformin—type 2 diabetes mellitus	6.62e-05	0.000259	CcSEcCtD
Oxycodone—Rash—Orlistat—type 2 diabetes mellitus	6.62e-05	0.000259	CcSEcCtD
Oxycodone—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000259	CcSEcCtD
Oxycodone—Dermatitis—Orlistat—type 2 diabetes mellitus	6.61e-05	0.000259	CcSEcCtD
Oxycodone—Headache—Orlistat—type 2 diabetes mellitus	6.58e-05	0.000257	CcSEcCtD
Oxycodone—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000257	CcSEcCtD
Oxycodone—Asthenia—Irbesartan—type 2 diabetes mellitus	6.55e-05	0.000256	CcSEcCtD
Oxycodone—Somnolence—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000256	CcSEcCtD
Oxycodone—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000254	CcSEcCtD
Oxycodone—Pruritus—Irbesartan—type 2 diabetes mellitus	6.46e-05	0.000253	CcSEcCtD
Oxycodone—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.4e-05	0.000251	CcSEcCtD
Oxycodone—Dizziness—Metformin—type 2 diabetes mellitus	6.4e-05	0.00025	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000249	CcSEcCtD
Oxycodone—Fatigue—Ramipril—type 2 diabetes mellitus	6.35e-05	0.000249	CcSEcCtD
Oxycodone—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.33e-05	0.000248	CcSEcCtD
Oxycodone—Nausea—Valsartan—type 2 diabetes mellitus	6.31e-05	0.000247	CcSEcCtD
Oxycodone—Constipation—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000247	CcSEcCtD
Oxycodone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000245	CcSEcCtD
Oxycodone—Nausea—Orlistat—type 2 diabetes mellitus	6.24e-05	0.000244	CcSEcCtD
Oxycodone—Asthenia—Losartan—type 2 diabetes mellitus	6.16e-05	0.000241	CcSEcCtD
Oxycodone—Vomiting—Metformin—type 2 diabetes mellitus	6.15e-05	0.000241	CcSEcCtD
Oxycodone—Rash—Metformin—type 2 diabetes mellitus	6.1e-05	0.000239	CcSEcCtD
Oxycodone—Dermatitis—Metformin—type 2 diabetes mellitus	6.09e-05	0.000239	CcSEcCtD
Oxycodone—Pruritus—Losartan—type 2 diabetes mellitus	6.08e-05	0.000238	CcSEcCtD
Oxycodone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000238	CcSEcCtD
Oxycodone—Headache—Metformin—type 2 diabetes mellitus	6.06e-05	0.000237	CcSEcCtD
Oxycodone—Dizziness—Irbesartan—type 2 diabetes mellitus	6.04e-05	0.000236	CcSEcCtD
Oxycodone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000236	CcSEcCtD
Oxycodone—Diarrhoea—Losartan—type 2 diabetes mellitus	5.88e-05	0.00023	CcSEcCtD
Oxycodone—Urticaria—Ramipril—type 2 diabetes mellitus	5.85e-05	0.000229	CcSEcCtD
Oxycodone—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000228	CcSEcCtD
Oxycodone—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000228	CcSEcCtD
Oxycodone—Vomiting—Irbesartan—type 2 diabetes mellitus	5.8e-05	0.000227	CcSEcCtD
Oxycodone—Rash—Irbesartan—type 2 diabetes mellitus	5.76e-05	0.000225	CcSEcCtD
Oxycodone—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.75e-05	0.000225	CcSEcCtD
Oxycodone—Nausea—Metformin—type 2 diabetes mellitus	5.75e-05	0.000225	CcSEcCtD
Oxycodone—Headache—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000224	CcSEcCtD
Oxycodone—Dizziness—Losartan—type 2 diabetes mellitus	5.68e-05	0.000222	CcSEcCtD
Oxycodone—Vomiting—Losartan—type 2 diabetes mellitus	5.46e-05	0.000214	CcSEcCtD
Oxycodone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000213	CcSEcCtD
Oxycodone—Nausea—Irbesartan—type 2 diabetes mellitus	5.42e-05	0.000212	CcSEcCtD
Oxycodone—Rash—Losartan—type 2 diabetes mellitus	5.42e-05	0.000212	CcSEcCtD
Oxycodone—Dermatitis—Losartan—type 2 diabetes mellitus	5.41e-05	0.000212	CcSEcCtD
Oxycodone—Headache—Losartan—type 2 diabetes mellitus	5.38e-05	0.000211	CcSEcCtD
Oxycodone—Asthenia—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000207	CcSEcCtD
Oxycodone—Pruritus—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000204	CcSEcCtD
Oxycodone—Nausea—Losartan—type 2 diabetes mellitus	5.1e-05	0.0002	CcSEcCtD
Oxycodone—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000197	CcSEcCtD
Oxycodone—Dizziness—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000191	CcSEcCtD
Oxycodone—Vomiting—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000183	CcSEcCtD
Oxycodone—Rash—Ramipril—type 2 diabetes mellitus	4.65e-05	0.000182	CcSEcCtD
Oxycodone—Dermatitis—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000182	CcSEcCtD
Oxycodone—Headache—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000181	CcSEcCtD
Oxycodone—Nausea—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000171	CcSEcCtD
Oxycodone—OPRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.07e-05	0.000151	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—LPL—type 2 diabetes mellitus	1.07e-05	0.00015	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.05e-05	0.000147	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.04e-05	0.000146	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	1.04e-05	0.000146	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.03e-05	0.000145	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.03e-05	0.000145	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.03e-05	0.000145	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	1.03e-05	0.000144	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	1.03e-05	0.000144	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.02e-05	0.000144	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.02e-05	0.000143	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.02e-05	0.000143	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	1.01e-05	0.000143	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.01e-05	0.000142	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—INS—type 2 diabetes mellitus	1e-05	0.000141	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	1e-05	0.000141	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	1e-05	0.000141	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.87e-06	0.000139	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	9.83e-06	0.000138	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	9.83e-06	0.000138	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.76e-06	0.000137	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.76e-06	0.000137	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.76e-06	0.000137	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.74e-06	0.000137	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.71e-06	0.000137	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.7e-06	0.000137	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.69e-06	0.000136	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.65e-06	0.000136	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	9.61e-06	0.000135	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.56e-06	0.000135	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	9.43e-06	0.000133	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	9.42e-06	0.000133	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.36e-06	0.000132	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.36e-06	0.000132	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	9.34e-06	0.000132	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	9.23e-06	0.00013	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	9.23e-06	0.00013	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.21e-06	0.00013	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.18e-06	0.000129	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	9.13e-06	0.000129	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	9.05e-06	0.000127	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	9.01e-06	0.000127	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	9.01e-06	0.000127	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	8.99e-06	0.000127	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	8.99e-06	0.000127	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	8.99e-06	0.000127	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	8.98e-06	0.000126	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	8.95e-06	0.000126	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	8.93e-06	0.000126	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.91e-06	0.000125	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.89e-06	0.000125	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.88e-06	0.000125	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.85e-06	0.000125	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	8.84e-06	0.000125	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.79e-06	0.000124	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.79e-06	0.000124	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	8.79e-06	0.000124	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	8.77e-06	0.000124	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.73e-06	0.000123	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.7e-06	0.000123	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.7e-06	0.000123	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.7e-06	0.000123	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.7e-06	0.000122	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.7e-06	0.000122	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	8.67e-06	0.000122	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.65e-06	0.000122	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.6e-06	0.000121	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.5e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.5e-06	0.00012	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	8.47e-06	0.000119	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.47e-06	0.000119	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.46e-06	0.000119	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	8.44e-06	0.000119	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	8.32e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.28e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.2e-06	0.000115	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.18e-06	0.000115	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	8.08e-06	0.000114	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.08e-06	0.000114	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	8.06e-06	0.000114	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	8.06e-06	0.000114	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	8.06e-06	0.000114	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	7.91e-06	0.000111	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	7.86e-06	0.000111	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	7.84e-06	0.00011	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	7.79e-06	0.00011	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.76e-06	0.000109	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	7.72e-06	0.000109	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.71e-06	0.000109	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.71e-06	0.000109	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	7.68e-06	0.000108	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.66e-06	0.000108	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	7.64e-06	0.000108	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	7.55e-06	0.000106	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.53e-06	0.000106	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	7.53e-06	0.000106	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.47e-06	0.000105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	7.43e-06	0.000105	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.42e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.4e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.4e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.4e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.4e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	7.38e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	7.33e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.31e-06	0.000103	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	7.29e-06	0.000103	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	7.29e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	7.26e-06	0.000102	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	7.24e-06	0.000102	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.19e-06	0.000101	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.18e-06	0.000101	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.15e-06	0.000101	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	7.11e-06	0.0001	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.09e-06	9.99e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.05e-06	9.93e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	7.01e-06	9.86e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	6.99e-06	9.84e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	6.99e-06	9.84e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.98e-06	9.83e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	6.95e-06	9.78e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.84e-06	9.63e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.83e-06	9.61e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	6.82e-06	9.59e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	6.7e-06	9.44e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	6.7e-06	9.44e-05	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.61e-06	9.3e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	6.6e-06	9.29e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.59e-06	9.28e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.55e-06	9.22e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.52e-06	9.17e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.52e-06	9.17e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.5e-06	9.16e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.5e-06	9.16e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	6.49e-06	9.14e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	6.47e-06	9.1e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	6.39e-06	9e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.33e-06	8.92e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.19e-06	8.71e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.16e-06	8.67e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.13e-06	8.64e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	6.13e-06	8.63e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.12e-06	8.62e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.03e-06	8.49e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.03e-06	8.49e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	6.03e-06	8.48e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.03e-06	8.48e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6e-06	8.45e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	6e-06	8.44e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	5.92e-06	8.33e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.91e-06	8.33e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.88e-06	8.27e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.88e-06	8.27e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.88e-06	8.27e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.84e-06	8.22e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.81e-06	8.19e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	5.75e-06	8.09e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.74e-06	8.08e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.7e-06	8.03e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.7e-06	8.03e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.67e-06	7.98e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	5.63e-06	7.93e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	5.59e-06	7.87e-05	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.58e-06	7.86e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.55e-06	7.82e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.53e-06	7.79e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	5.52e-06	7.78e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.5e-06	7.74e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	5.49e-06	7.72e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	5.37e-06	7.56e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	5.35e-06	7.54e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.27e-06	7.42e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.27e-06	7.42e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.27e-06	7.42e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.23e-06	7.36e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	5.21e-06	7.34e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.17e-06	7.29e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.17e-06	7.28e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.15e-06	7.25e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.13e-06	7.22e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.1e-06	7.18e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.07e-06	7.14e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	5.07e-06	7.13e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.02e-06	7.07e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5e-06	7.04e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.94e-06	6.95e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.85e-06	6.82e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	4.84e-06	6.82e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	4.84e-06	6.82e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.82e-06	6.79e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.82e-06	6.79e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.77e-06	6.71e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.77e-06	6.71e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.69e-06	6.61e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.69e-06	6.61e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.61e-06	6.5e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.6e-06	6.47e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.57e-06	6.44e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.57e-06	6.44e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.55e-06	6.4e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	4.43e-06	6.24e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.38e-06	6.17e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.31e-06	6.07e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.22e-06	5.95e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.04e-06	5.69e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.01e-06	5.64e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.94e-06	5.55e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.94e-06	5.55e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.93e-06	5.53e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.92e-06	5.52e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.87e-06	5.45e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.84e-06	5.41e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.76e-06	5.29e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.65e-06	5.14e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.6e-06	5.07e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.59e-06	5.05e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.54e-06	4.99e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.51e-06	4.94e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.5e-06	4.93e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.45e-06	4.85e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.45e-06	4.85e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.41e-06	4.8e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.37e-06	4.74e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.25e-06	4.57e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.23e-06	4.55e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.17e-06	4.46e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.15e-06	4.44e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	3.08e-06	4.34e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.07e-06	4.32e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.02e-06	4.25e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.01e-06	4.23e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3e-06	4.22e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.97e-06	4.18e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.62e-06	3.69e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.57e-06	3.62e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.35e-06	3.32e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.25e-06	3.17e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.25e-06	3.17e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	2.23e-06	3.14e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.06e-06	2.9e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.58e-06	2.23e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.04e-06	1.46e-05	CbGpPWpGaD
